Clinical trial
A Phase I/IIa Study of Decitabine in Combination With Genistein in Pediatric Patients With Relapsed or Refractory Solid Tumors and Leukemia
NCT02499861 is registered in ClinicalTrials.gov with St. Justine's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/IIa Study of Decitabine in Combination With Genistein in Pediatric Patients With Relapsed or Refractory Solid Tumors and Leukemia
- Lead sponsor
- St. Justine's Hospital
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- July 31, 2015
- Completion date
- October 24, 2017
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer